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It is generally accepted that the uremic state of patients with end-stage renal disease is highly pro-inflammatory and 
pro-oxidant. Moreover, the contact with the dialyzer’s membrane activates the leucocytes and further increases the 
inflammation and oxidative stress. Therefore, numerous approaches have been proposed for reduction of oxidative 
stress in hemodialysed patients, from antioxidant therapy through diet rich in natural antioxidants to the improvement 
of dialyser’s membrane.  
The changes in the oxidative status of hemodialysed patients, which resulted from above mentioned interventions, as 
well as from a single hemodialysis session itself, were assessed by different methods, some of them similar to those 
included in our study.  
We present here a comparison of two methods for assessment of total plasma antioxidants, which provides a new 
insight into the past and future studies of oxidative stress research, especially in chronically hemodialysed patients. 
Patients before hemodialysis had significantly higher BAP values compared to the healthy controls (p<0,01). As a result 
of the hemodialysis session the average BAP value dropped with 12,6% (p<0,001 when compared to the values before 
hemodialysis). The BAP values measured after the hemodialysis were significantly lower than those of healthy controls 
(p<0,01).  
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BAP: This assay is based on the ability of a colored 
thiocyanate-derived substrate, which contains bounded Fe3+ 
ions, to discolor when Fe3+ ions are reduced to Fe2+. The 
intensity of discoloration is assessed photometrically, by 
measuring the absorbance at 505 nm, and the amount of 
reduced ferric ions is calculated. The results of the test are 
expressed as μEq ferric ions reducing antioxidants per L of 
sample. 
TAS: This method is based on the reduction of colored 
ABTS radical to colorless reduced form by the 
antioxidants which are present in the sample. The 
absorbance is measured at 660 nm. The method is 
calibrated with the vitamin E analog known as Trolox 
Equivalent, and the results are expressed in μmol/L. 
When measured by the TAS assay, patients 
before hemodialysis again had higher 
values of total antioxidants than controls, 
but the difference showed higher statistical 
significance: p<0,001. As a result of the 
hemodialysis session the average TAS value 
decreased more (35,2%) than that of BAP 
(p<0,001 when compared to the values 
before hemodialysis). The TAS values 
measured after the hemodialysis were 
lower than those measured in healthy 
controls, but this difference was not 
statistically significant. 
